Germany
Japan
United Kingdom
China
Research Areas
View as table Download
Rabbit polyclonal HLA-G Antibody (Center)
| Applications | FC, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This HLA-G antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 62-89 amino acids from the Central region of human HLA-G. |
Phospho-RAC1-S71 Rabbit Polyclonal Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | A phospho specific peptide corresponding to residues surrounding S71 of human RAC1 |
Rabbit Polyclonal Antibody against CD19 (N-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This CD19 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 143-172 amino acids from the N-terminal region of human CD19. |
Rabbit polyclonal PECAM-1 (Ab-713) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human PECAM-1 around the phosphorylation site of tyrosine 713 (T-V-YP-S-E). |
Rabbit Polyclonal JNK1/2/3 (Thr183+Tyr185) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human JNK1/2/3 around the phosphorylation site of Threonine 183+Tyrosine 185 |
| Modifications | Phospho-specific |
LRP5 + LRP6 rabbit polyclonal antibody, Aff - Purified
| Applications | WB |
| Reactivities | Human, Mouse |
| Immunogen | Synthetic peptide surrounding amino acid 437 of Human LRP. |
Rabbit polyclonal ROR2 Antibody (N-term)
| Applications | FC, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This ROR2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 19-50 amino acids from the N-terminal region of human ROR2. |
Rabbit Polyclonal CD4 Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat, Rabbit |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide made to an C-terminal region of the human CD4 protein (within residues 400-458). [Swiss-Prot P01730] |
Rabbit polyclonal IL1R Antibody (C-term E487)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This IL1R antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 474-503 amino acids from the C-terminal region of human IL1R. |
Rabbit polyclonal antibody to CD41/Integrin alpha 2b (integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41))
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 210 and 532 of Integrin alpha 2b (Uniprot ID#P08514) |
Rabbit Polyclonal Antibody against CD8A (N-term)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This CD8A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 59-88 amino acids from the N-terminal region of human CD8A. |
Rabbit polyclonal PECAM-1 (Tyr713) antibody(Phospho-specific)
| Applications | IF, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human PECAM-1 around the phosphorylation site of tyrosine 713 (T-V-YP-S-E). |
| Modifications | Phospho-specific |
Rabbit polyclonal anti-APC10 antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This affinity purified antibody was prepared from whole rabbit serum produced by repeated immunizations with a synthetic peptide corresponding to amino acids near the amino terminus of human APC10. |
Rabbit polyclonal anti-IL6 antibody
| Applications | WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Immunogen | Anti-IL-6 is an IgG fraction antibody prepared from rabbit antiserum after repeated immunizations with recombinant mouse IL-6 protein produced in E.coli. |
Rabbit Polyclonal ROCK1 Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human ROCK1 |
Rabbit Polyclonal JNK1/2/3 Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human JNK1/2/3 |
Anti-ITGAX Rabbit Polyclonal Antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region derived from 1150-1163 amino acids of Human integrin, alpha X (complement component 3 receptor 4 subunit) |
Rabbit Monoclonal CD3 Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Rabbit Polyclonal Anti-WNT2 Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide of human WNT2 |
Active filters
Filter by
Target Symbol
Reactivities
Clonalities
Conjugates
Modifications
Families
- Druggable Genome (32)
- Transmembrane (23)
- ES Cell Differentiation/IPS (11)
- Protein Kinase (6)
- Secreted Protein (6)
- Adult stem cells (3)
- GPCR (2)
- Protease (2)
- Cancer stem cells (1)
- Induced pluripotent stem cells (1)
- Stem cell - Pluripotency (1)
- Stem cell relevant signaling - Wnt Signaling pathway (1)
- Transcription Factors (1)
Pathways
- Hematopoietic cell lineage (10)
- Cell adhesion molecules (CAMs) (8)
- MAPK signaling pathway (7)
- Pathways in cancer (7)
- Toll-like receptor signaling pathway (7)
- Wnt signaling pathway (7)
- Cytokine-cytokine receptor interaction (6)
- Colorectal cancer (5)
- Focal adhesion (5)
- NOD-like receptor signaling pathway (5)
- T cell receptor signaling pathway (5)
- Fc epsilon RI signaling pathway (4)
- Leukocyte transendothelial migration (4)
- Neurotrophin signaling pathway (4)
- Primary immunodeficiency (4)
- Regulation of actin cytoskeleton (4)
- Adipocytokine signaling pathway (3)
- Allograft rejection (3)
- Alzheimer's disease (3)
- Amyotrophic lateral sclerosis (ALS) (3)
- Antigen processing and presentation (3)
- Apoptosis (3)
- Basal cell carcinoma (3)
- Epithelial cell signaling in Helicobacter pylori infection (3)
- Graft-versus-host disease (3)
- Melanogenesis (3)
- Natural killer cell mediated cytotoxicity (3)
- Pancreatic cancer (3)
- Progesterone-mediated oocyte maturation (3)
- RIG-I-like receptor signaling pathway (3)
- Type I diabetes mellitus (3)
- Type II diabetes mellitus (3)
- Asthma (2)
- Autoimmune thyroid disease (2)
- Axon guidance (2)
- B cell receptor signaling pathway (2)
- Chemokine signaling pathway (2)
- Cytosolic DNA-sensing pathway (2)
- Dilated cardiomyopathy (2)
- ErbB signaling pathway (2)
- GnRH signaling pathway (2)
- Hypertrophic cardiomyopathy (HCM) (2)
- Insulin signaling pathway (2)
- Pathogenic Escherichia coli infection (2)
- Renin-angiotensin system (2)
- Systemic lupus erythematosus (2)
- TGF-beta signaling pathway (2)
- Viral myocarditis (2)
- Adherens junction (1)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (1)
- Cell cycle (1)
- Complement and coagulation cascades (1)
- ECM-receptor interaction (1)
- Endocytosis (1)
- Fc gamma R-mediated phagocytosis (1)
- Glutathione metabolism (1)
- Hedgehog signaling pathway (1)
- Jak-STAT signaling pathway (1)
- Metabolic pathways (1)
- Oocyte meiosis (1)
- Prion diseases (1)
- Renal cell carcinoma (1)
- Small cell lung cancer (1)
- Ubiquitin mediated proteolysis (1)
- VEGF signaling pathway (1)
- Vascular smooth muscle contraction (1)